AU2009225416A1 - Methods, devices and compositions for adhering hydrated polymer implants to bone - Google Patents
Methods, devices and compositions for adhering hydrated polymer implants to bone Download PDFInfo
- Publication number
- AU2009225416A1 AU2009225416A1 AU2009225416A AU2009225416A AU2009225416A1 AU 2009225416 A1 AU2009225416 A1 AU 2009225416A1 AU 2009225416 A AU2009225416 A AU 2009225416A AU 2009225416 A AU2009225416 A AU 2009225416A AU 2009225416 A1 AU2009225416 A1 AU 2009225416A1
- Authority
- AU
- Australia
- Prior art keywords
- bone
- implant
- polymer
- isocyanate
- containing compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920000642 polymer Polymers 0.000 title claims description 187
- 239000007943 implant Substances 0.000 title claims description 166
- 210000000988 bone and bone Anatomy 0.000 title claims description 162
- 238000000034 method Methods 0.000 title claims description 75
- 239000000203 mixture Substances 0.000 title description 11
- 239000004814 polyurethane Substances 0.000 claims description 80
- 229920002635 polyurethane Polymers 0.000 claims description 79
- 239000012948 isocyanate Substances 0.000 claims description 63
- 150000002513 isocyanates Chemical class 0.000 claims description 63
- -1 poly(ethylene glycol) Polymers 0.000 claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 51
- 239000012815 thermoplastic material Substances 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 23
- 229920002125 Sokalan® Polymers 0.000 claims description 21
- 125000000524 functional group Chemical group 0.000 claims description 16
- 229920002988 biodegradable polymer Polymers 0.000 claims description 14
- 239000004621 biodegradable polymer Substances 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 11
- 210000000845 cartilage Anatomy 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 210000003127 knee Anatomy 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 230000005855 radiation Effects 0.000 claims description 8
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 7
- 210000003423 ankle Anatomy 0.000 claims description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 6
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 6
- 210000000707 wrist Anatomy 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 239000001506 calcium phosphate Substances 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 5
- 230000003601 intercostal effect Effects 0.000 claims description 5
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 5
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 4
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 4
- 229940112869 bone morphogenetic protein Drugs 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 230000000278 osteoconductive effect Effects 0.000 claims description 4
- 229920002401 polyacrylamide Polymers 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims description 4
- 229920001169 thermoplastic Polymers 0.000 claims description 4
- 239000004416 thermosoftening plastic Substances 0.000 claims description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- 229940122361 Bisphosphonate Drugs 0.000 claims description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 3
- 239000005058 Isophorone diisocyanate Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 150000004663 bisphosphonates Chemical class 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 claims description 3
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 3
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000011243 crosslinked material Substances 0.000 claims description 2
- 238000003825 pressing Methods 0.000 claims description 2
- 230000007480 spreading Effects 0.000 claims description 2
- 238000003892 spreading Methods 0.000 claims description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 230000000379 polymerizing effect Effects 0.000 claims 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 description 41
- 239000000463 material Substances 0.000 description 32
- 239000010410 layer Substances 0.000 description 24
- 239000000853 adhesive Substances 0.000 description 20
- 230000001070 adhesive effect Effects 0.000 description 20
- 239000002639 bone cement Substances 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 210000001624 hip Anatomy 0.000 description 8
- 238000002513 implantation Methods 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 229920001692 polycarbonate urethane Polymers 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 7
- 210000001503 joint Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 239000004970 Chain extender Substances 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 4
- 210000000588 acetabulum Anatomy 0.000 description 4
- 238000011882 arthroplasty Methods 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 208000006386 Bone Resorption Diseases 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000002805 bone matrix Anatomy 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- 125000002843 carboxylic acid group Chemical group 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 210000001513 elbow Anatomy 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 201000008482 osteoarthritis Diseases 0.000 description 3
- 229920003226 polyurethane urea Polymers 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000002832 shoulder Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 102000007547 Laminin Human genes 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 102000016611 Proteoglycans Human genes 0.000 description 2
- 108010067787 Proteoglycans Proteins 0.000 description 2
- 239000002998 adhesive polymer Substances 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 229960001714 calcium phosphate Drugs 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000004202 carbamide Chemical group 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- HIWGDJVTAWTBNH-UHFFFAOYSA-N 2-methylidene-5-sulfopentanoic acid Chemical compound OC(=O)C(=C)CCCS(O)(=O)=O HIWGDJVTAWTBNH-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 208000007353 Hip Osteoarthritis Diseases 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- VNWKTOKETHGBQD-YPZZEJLDSA-N carbane Chemical compound [10CH4] VNWKTOKETHGBQD-YPZZEJLDSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- OYQYHJRSHHYEIG-UHFFFAOYSA-N ethyl carbamate;urea Chemical compound NC(N)=O.CCOC(N)=O OYQYHJRSHHYEIG-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 208000020089 femoral neck fracture Diseases 0.000 description 1
- 210000002436 femur neck Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000012977 invasive surgical procedure Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940102838 methylmethacrylate Drugs 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000037074 physically active Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011527 polyurethane coating Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000003361 porogen Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000010512 thermal transition Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000011541 total hip replacement Methods 0.000 description 1
- AVWRKZWQTYIKIY-UHFFFAOYSA-N urea-1-carboxylic acid Chemical compound NC(=O)NC(O)=O AVWRKZWQTYIKIY-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0094—Physical treatment, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/068—Use of macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Plasma & Fusion (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7030508P | 2008-03-21 | 2008-03-21 | |
| US61/070,305 | 2008-03-21 | ||
| PCT/US2009/037979 WO2009117737A2 (en) | 2008-03-21 | 2009-03-23 | Methods, devices and compositions for adhering hydrated polymer implants to bone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2009225416A1 true AU2009225416A1 (en) | 2009-09-24 |
Family
ID=40873290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009225416A Abandoned AU2009225416A1 (en) | 2008-03-21 | 2009-03-23 | Methods, devices and compositions for adhering hydrated polymer implants to bone |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20090240337A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2268331A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2011515162A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009225416A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2718718A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009117737A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090088846A1 (en) | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
| US20120209396A1 (en) | 2008-07-07 | 2012-08-16 | David Myung | Orthopedic implants having gradient polymer alloys |
| JP5752035B2 (ja) * | 2008-07-07 | 2015-07-22 | バイオミメディカ インコーポレイテッド | 疎水性ポリマーに由来する親水性相互貫入ポリマーネットワーク |
| US8497023B2 (en) * | 2008-08-05 | 2013-07-30 | Biomimedica, Inc. | Polyurethane-grafted hydrogels |
| US10258473B2 (en) * | 2008-11-19 | 2019-04-16 | Softjoint Corporation | Device and method for restoring joints with artificial cartilage |
| JP5544719B2 (ja) * | 2009-01-27 | 2014-07-09 | 三菱レイヨン株式会社 | ゲルおよびその製造方法 |
| WO2010099463A2 (en) | 2009-02-27 | 2010-09-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Joint bioscaffolds |
| US9439685B2 (en) * | 2009-05-12 | 2016-09-13 | Bullard Spine, Llc | Multi-layer osteoinductive, osteogenic, and osteoconductive carrier |
| WO2011041774A1 (en) * | 2009-10-02 | 2011-04-07 | Osman Said G | Biologic diarthrodial joint |
| CA2808528A1 (en) | 2010-08-27 | 2012-03-01 | Biomimedica, Inc. | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same |
| EP2465549A1 (en) * | 2010-11-17 | 2012-06-20 | Zimmer GmbH | Porous metal structures made from polymer preforms |
| EP3235522A1 (en) * | 2011-01-10 | 2017-10-25 | Biomimedica, Inc | Orthopedic implants having gradient polymer alloys |
| US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
| US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| JP6147747B2 (ja) * | 2011-08-25 | 2017-06-14 | シンセス・ゲーエムベーハーＳｙｎｔｈｅｓ ＧｍｂＨ | 未硬化ポリマーの接着層を備えるｐｅｅｋ又はｐｍｍａ製の透明なインプラント |
| CA2885996A1 (en) | 2011-10-03 | 2013-04-11 | Biomimedica, Inc. | Polymeric adhesive for anchoring compliant materials to another surface |
| EP3335673B1 (en) | 2011-11-21 | 2025-07-30 | Hyalex Orthopaedics, Inc. | Systems for anchoring orthopaedic implants to bone |
| WO2013126294A1 (en) | 2012-02-23 | 2013-08-29 | The Board Of Trustees Of The Leland Stanford Junior University | Injectable hydrogel system to modulate host response at bone implant interface |
| US20140142689A1 (en) | 2012-11-21 | 2014-05-22 | Didier De Canniere | Device and method of treating heart valve malfunction |
| US9566443B2 (en) | 2013-11-26 | 2017-02-14 | Corquest Medical, Inc. | System for treating heart valve malfunction including mitral regurgitation |
| AU2015231110B2 (en) | 2014-03-21 | 2019-03-07 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix |
| SG11201610671PA (en) | 2014-09-07 | 2017-01-27 | Ossio Ltd | Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof |
| US10842626B2 (en) | 2014-12-09 | 2020-11-24 | Didier De Canniere | Intracardiac device to correct mitral regurgitation |
| AU2015370600B2 (en) | 2014-12-26 | 2020-07-23 | Ossio Ltd | Continuous-fiber reinforced biocomposite medical implants |
| US20160331539A1 (en) * | 2015-05-12 | 2016-11-17 | Elwha Llc | Modifiable implants |
| US11077228B2 (en) | 2015-08-10 | 2021-08-03 | Hyalex Orthopaedics, Inc. | Interpenetrating polymer networks |
| US10869954B2 (en) * | 2016-03-07 | 2020-12-22 | Ossio, Ltd. | Surface treated biocomposite material, medical implants comprising same and methods of treatment thereof |
| US11491264B2 (en) | 2016-06-27 | 2022-11-08 | Ossio Ltd. | Fiber reinforced biocomposite medical implants with high mineral content |
| WO2019203974A1 (en) * | 2018-04-20 | 2019-10-24 | President And Fellows Of Harvard College | Topological adhesion of materials |
| US10869950B2 (en) | 2018-07-17 | 2020-12-22 | Hyalex Orthopaedics, Inc. | Ionic polymer compositions |
| USD945620S1 (en) | 2020-01-29 | 2022-03-08 | Biopoly, Llc | Great toe implant |
| US11801143B2 (en) | 2021-07-01 | 2023-10-31 | Hyalex Orthopaedics, Inc. | Multi-layered biomimetic osteochondral implants and methods of using thereof |
| IL294542A (en) | 2021-07-19 | 2023-02-01 | Ossio Ltd | A device with a tube for inserting implants with an adjustable insertion depth |
Family Cites Families (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2914737C3 (de) * | 1979-04-11 | 1981-12-10 | Feldmühle AG, 4000 Düsseldorf | Hüftkopf-Kappen-Endoprothese |
| US4320709A (en) * | 1980-09-29 | 1982-03-23 | Pyro-Sciences, Inc. | Hazardous materials incineration system |
| US4439583A (en) * | 1980-11-12 | 1984-03-27 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions useful in forming canulae |
| US4502161A (en) * | 1981-09-21 | 1985-03-05 | Wall W H | Prosthetic meniscus for the repair of joints |
| US4500676A (en) * | 1983-12-15 | 1985-02-19 | Biomatrix, Inc. | Hyaluronate modified polymeric articles |
| US4575539A (en) * | 1985-06-03 | 1986-03-11 | E. R. Squibb & Sons, Inc. | Drug delivery systems including novel interpenetrating polymer networks and method |
| US5112350A (en) * | 1986-10-16 | 1992-05-12 | Cbs Lens, A California General Partnership | Method for locating on a cornea an artificial lens fabricated from a collagen-hydrogel for promoting epithelial cell growth and regeneration of the stroma |
| US5114627A (en) * | 1986-10-16 | 1992-05-19 | Cbs Lens | Method for producing a collagen hydrogel |
| US5290548A (en) * | 1987-04-10 | 1994-03-01 | University Of Florida | Surface modified ocular implants, surgical instruments, devices, prostheses, contact lenses and the like |
| US5094876A (en) * | 1987-04-10 | 1992-03-10 | University Of Florida | Surface modified surgical instruments, devices, implants, contact lenses and the like |
| US5100689A (en) * | 1987-04-10 | 1992-03-31 | University Of Florida | Surface modified surgical instruments, devices, implants, contact lenses and the like |
| US5282851A (en) * | 1987-07-07 | 1994-02-01 | Jacob Labarre Jean | Intraocular prostheses |
| US5087392A (en) * | 1988-05-31 | 1992-02-11 | Sola Usa, Inc. | Method of mold contact lenses |
| US5115056A (en) * | 1989-06-20 | 1992-05-19 | Ciba-Geigy Corporation | Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymers and contact lenses thereof |
| IE65208B1 (en) * | 1990-01-25 | 1995-10-04 | Howmedia Inc | Bone cement |
| CA2101773A1 (en) * | 1991-01-31 | 1992-08-01 | Toyoichi Tanaka | Interpenetrating-polymer network phase-transition gels |
| JP3007903B2 (ja) * | 1991-03-29 | 2000-02-14 | 京セラ株式会社 | 人工椎間板 |
| AU650156B2 (en) * | 1992-08-05 | 1994-06-09 | Lions Eye Institute Limited | Keratoprosthesis and method of producing the same |
| AU4997393A (en) * | 1992-08-07 | 1994-03-03 | Keravision, Inc. | Hybrid intrastromal corneal ring |
| US5556429A (en) * | 1994-05-06 | 1996-09-17 | Advanced Bio Surfaces, Inc. | Joint resurfacing system |
| US5591170A (en) * | 1994-10-14 | 1997-01-07 | Genesis Orthopedics | Intramedullary bone cutting saw |
| US6027742A (en) * | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
| CA2237192C (en) * | 1995-11-15 | 2006-06-20 | Seikagaku Corporation | Photocured crosslinked-hyaluronic acid gel and method of preparation thereof |
| JP2000507997A (ja) * | 1996-02-09 | 2000-06-27 | サーフェス ソルーションズ ラボラトリーズ インコーポレイテッド | 水性の親水性被覆組成物及びそれから製造した物品 |
| US5817704A (en) * | 1996-03-08 | 1998-10-06 | The Procter & Gamble Company | Heterogeneous foam materials |
| FR2749753B1 (fr) * | 1996-06-14 | 1998-12-24 | Mosseri Raphael | Prothese totale de hanche destinee a etre posee par voie endo-articulaire et son dispositif ancillaire |
| CN1208336A (zh) * | 1996-11-13 | 1999-02-17 | 株式会社美你康 | 人工角膜 |
| US5904927A (en) * | 1997-03-14 | 1999-05-18 | Northeastern University | Drug delivery using pH-sensitive semi-interpenetrating network hydrogels |
| US6224893B1 (en) * | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
| US5981826A (en) * | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
| US6053251A (en) * | 1997-05-15 | 2000-04-25 | Halliburton Energy Services, Inc. | Reduced travel operating mechanism for downhole tools |
| US6221467B1 (en) * | 1997-06-03 | 2001-04-24 | Scimed Life Systems, Inc. | Coating gradient for lubricious coatings on balloon catheters |
| AU758800B2 (en) * | 1998-02-23 | 2003-03-27 | Gkss-Forschungszentrum Geesthacht Gmbh | Shape memory polymers |
| US7019192B2 (en) * | 1998-02-27 | 2006-03-28 | Musculoskeletal Transplant Foundation | Composition for filling bone defects |
| US6057406A (en) * | 1998-08-03 | 2000-05-02 | The University Of Southern Mississippi | Functionally gradient polymeric materials |
| US6361560B1 (en) * | 1998-12-23 | 2002-03-26 | Anamed, Inc. | Corneal implant and method of manufacture |
| WO2000043050A1 (en) * | 1999-01-22 | 2000-07-27 | St. Jude Medical, Inc. | Medical adhesives |
| US6376742B1 (en) * | 1999-02-17 | 2002-04-23 | Richard J. Zdrahala | In vivo tissue engineering with biodegradable polymers |
| US6239209B1 (en) * | 1999-02-23 | 2001-05-29 | Reichhold, Inc. | Air curable water-borne urethane-acrylic hybrids |
| US6332887B1 (en) * | 1999-04-06 | 2001-12-25 | Benjamin D. Knox | Spinal fusion instrumentation system |
| US6673079B1 (en) * | 1999-08-16 | 2004-01-06 | Washington University | Device for lengthening and reshaping bone by distraction osteogenesis |
| US7008635B1 (en) * | 1999-09-10 | 2006-03-07 | Genzyme Corporation | Hydrogels for orthopedic repair |
| US6264695B1 (en) * | 1999-09-30 | 2001-07-24 | Replication Medical, Inc. | Spinal nucleus implant |
| US7547324B2 (en) * | 2000-02-16 | 2009-06-16 | Trans1, Inc. | Spinal mobility preservation apparatus having an expandable membrane |
| US6626945B2 (en) * | 2000-03-14 | 2003-09-30 | Chondrosite, Llc | Cartilage repair plug |
| US6689165B2 (en) * | 2000-03-31 | 2004-02-10 | Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College | Surface modifications for enhanced epithelialization |
| US6846875B2 (en) * | 2000-04-10 | 2005-01-25 | Pharmacia Groningen Bv | Hydrogels and methods for their production |
| US6372815B1 (en) * | 2000-04-18 | 2002-04-16 | Ocular Sciences Inc | Ophthalmic lenses and compositions, and methods for producing same |
| US6679917B2 (en) * | 2000-05-01 | 2004-01-20 | Arthrosurface, Incorporated | System and method for joint resurface repair |
| EP2314257B9 (en) * | 2000-05-01 | 2013-02-27 | ArthroSurface, Inc. | System for joint resurface repair |
| US7678151B2 (en) * | 2000-05-01 | 2010-03-16 | Ek Steven W | System and method for joint resurface repair |
| US7163541B2 (en) * | 2002-12-03 | 2007-01-16 | Arthrosurface Incorporated | Tibial resurfacing system |
| AU2002220570A1 (en) * | 2000-09-28 | 2002-04-08 | Novartis Pharma Gmbh | Fenestrated lens for increased tear flow and method for making the same |
| US6524327B1 (en) * | 2000-09-29 | 2003-02-25 | Praxis, Llc | In-situ bonds |
| MXPA03007521A (es) * | 2001-03-02 | 2003-12-04 | Woodwelding Ag | Implantes, dispositivo y metodo para unir partes de tejido. |
| JP4340067B2 (ja) * | 2001-04-23 | 2009-10-07 | ウィスコンシン アルムニ リサーチ ファウンデイション | 二機能性改変ハイドロゲル |
| US6844028B2 (en) * | 2001-06-26 | 2005-01-18 | Accelr8 Technology Corporation | Functional surface coating |
| US6747090B2 (en) * | 2001-07-16 | 2004-06-08 | Pharmacia Groningen Bv | Compositions capable of forming hydrogels in the eye |
| DE10150737A1 (de) * | 2001-10-15 | 2003-04-30 | Hilti Ag | Mehrkomponenten-Ortschaumsystem und dessen Verwendung |
| JP2005517802A (ja) * | 2002-02-15 | 2005-06-16 | ゼットエムエス エルエルシー | 生物医学用途のための重合方法および材料 |
| US6955716B2 (en) * | 2002-03-01 | 2005-10-18 | American Dental Association Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
| DE10217351B3 (de) * | 2002-04-18 | 2004-02-12 | Mnemoscience Gmbh | Interpenetrierende Netzwerke |
| AU2002309026A1 (en) * | 2002-05-01 | 2003-11-17 | Hokkaido Technology Licensing Office Co., Ltd. | Gel having multiple network structure and method for preparation thereof |
| US7235102B2 (en) * | 2002-05-10 | 2007-06-26 | Ferree Bret A | Prosthetic components with contained compressible resilient members |
| US7476398B1 (en) * | 2002-06-28 | 2009-01-13 | Universite Laval | Corneal implant and uses thereof |
| ES2309350T3 (es) * | 2002-07-11 | 2008-12-16 | Advanced Bio Surfaces, Inc. | Metodo y equipo para artroplastia interposicional. |
| EP1545798A4 (en) * | 2002-08-02 | 2006-06-14 | Us Gov Health & Human Serv | NETWORKED NITROGEN OXIDE RELEASING POLYAMINE-COATED SUBSTRATES, THESE COMPOSITIONS AND MANUFACTURING PROCESSES DAF R |
| US20040028804A1 (en) * | 2002-08-07 | 2004-02-12 | Anderson Daniel G. | Production of polymeric microarrays |
| US7959636B2 (en) * | 2002-08-15 | 2011-06-14 | Arthrex, Inc. | Osteochondral repair using plug fashioned from whole distal femur or condyle formed of hydrogel composition |
| US7264634B2 (en) * | 2002-09-20 | 2007-09-04 | Arthrex, Inc. | Method and instrumentation for osteochondral repair using preformed implants |
| US8673333B2 (en) * | 2002-09-25 | 2014-03-18 | The Johns Hopkins University | Cross-linked polymer matrices, and methods of making and using same |
| US7049351B2 (en) * | 2002-11-01 | 2006-05-23 | Novartis Ag | Moldings and preparation and uses thereof |
| US6733533B1 (en) * | 2002-11-19 | 2004-05-11 | Zimmer Technology, Inc. | Artificial spinal disc |
| US20060127878A1 (en) * | 2002-12-18 | 2006-06-15 | Salomon David H | Hydrogel preparation and process of manufacture thereof |
| WO2004065450A2 (en) * | 2003-01-16 | 2004-08-05 | Carnegie Mellon University | Biodegradable polyurethanes and use thereof |
| US7160305B2 (en) * | 2003-03-07 | 2007-01-09 | Arthrex, Inc. | Retrodrill technique for insertion of autograft, allograft or synthetic osteochondral implants |
| US7758497B2 (en) * | 2003-06-20 | 2010-07-20 | Contura A/S | Endoscopic attachment device |
| US7176247B1 (en) * | 2003-06-27 | 2007-02-13 | The United States Of America As Represented By The Secretary Of The Army | Interpenetrating polymer network |
| US7582698B2 (en) * | 2003-07-02 | 2009-09-01 | Lubrizol Advanced Materials, Inc. | Water dispersions of non-uniform polyurethane particles |
| EP1680151A1 (en) * | 2003-08-08 | 2006-07-19 | Contura S.A. | Implantable hydrogel with resorbable shell for use as an endoprothesis |
| US10583220B2 (en) * | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
| US7217294B2 (en) * | 2003-08-20 | 2007-05-15 | Histogenics Corp. | Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and method for use thereof |
| US20050054774A1 (en) * | 2003-09-09 | 2005-03-10 | Scimed Life Systems, Inc. | Lubricious coating |
| US7544381B2 (en) * | 2003-09-09 | 2009-06-09 | Boston Scientific Scimed, Inc. | Lubricious coatings for medical device |
| US20050113836A1 (en) * | 2003-11-25 | 2005-05-26 | Lozier Antony J. | Expandable reamer |
| HUE028552T2 (en) * | 2004-02-20 | 2016-12-28 | Woodwelding Ag | An implant for implantation into bone tissue and a method for preparing it |
| US20070100457A1 (en) * | 2004-03-04 | 2007-05-03 | Hyde Edward R Jr | Paramagnetic liquid interface |
| WO2006013612A1 (ja) * | 2004-06-18 | 2006-02-09 | Hokkaido Technology Licensing Office Co., Ltd. | 人工半月板 |
| EP1611877A1 (en) * | 2004-06-28 | 2006-01-04 | Universidade de Coimbra | Method for preparing sustained-release therapeutic ophthalmic articles using compressed fluids for impregnation of drugs |
| EP1627615A3 (en) * | 2004-08-18 | 2006-11-02 | Arthrex, Inc. | Modular joint replacement implant with hydrogel surface |
| US7857849B2 (en) * | 2004-10-05 | 2010-12-28 | The Board Of Trustees Of The Leland Stanford Junior Iniversity | Artificial corneal implant |
| US20090088846A1 (en) * | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
| TW200640061A (en) * | 2005-01-04 | 2006-11-16 | Hitachi Chemical Co Ltd | Phase separation type polymer electrolyte film, electrode/phase separation type polymer electrolyte film assembly employing the same, processes for producing the same, and fuel cell employing the same |
| US7547319B2 (en) * | 2005-06-15 | 2009-06-16 | Ouroboros Medical | Mechanical apparatus and method for artificial disc replacement |
| US7651701B2 (en) * | 2005-08-29 | 2010-01-26 | Sanatis Gmbh | Bone cement composition and method of making the same |
| DE102005042381A1 (de) * | 2005-09-06 | 2007-03-08 | Herbert Kannegiesser Gmbh | Verfahren und Vorrichtung zum Waschen und/oder Schleudern von Wäsche |
| US8420605B2 (en) * | 2005-09-07 | 2013-04-16 | The University Of Strathclyde | Hydrogel compositions |
| US20070088444A1 (en) * | 2005-10-13 | 2007-04-19 | Robert A Hodorek | Method for repairing a bone defect using a formable implant which hardens in vivo |
| WO2007062079A2 (en) * | 2005-11-21 | 2007-05-31 | Philipp Lang | Devices and methods for treating facet joints, uncovertebral joints, costovertebral joints and other joints |
| EP2340855A1 (en) * | 2005-12-07 | 2011-07-06 | Zimmer, Inc. | Methods of modifying hydrogels using irradiation |
| US8110242B2 (en) * | 2006-03-24 | 2012-02-07 | Zimmer, Inc. | Methods of preparing hydrogel coatings |
| US20080058954A1 (en) * | 2006-08-22 | 2008-03-06 | Hai Trieu | Methods of treating spinal injuries using injectable flowable compositions comprising organic materials |
| US7731988B2 (en) * | 2007-08-03 | 2010-06-08 | Zimmer, Inc. | Multi-polymer hydrogels |
| US20090062423A1 (en) * | 2007-08-29 | 2009-03-05 | Salumedica, Llc | Orthopaedic cement mixtures with low weight percent polyvinyl alcohol (pva) solution |
| US8062739B2 (en) * | 2007-08-31 | 2011-11-22 | Zimmer, Inc. | Hydrogels with gradient |
| US20100056646A1 (en) * | 2008-03-12 | 2010-03-04 | Shalaby Shalaby W | Hydroswellable, segmented, aliphatic polyurethane ureas and intra-articular devices therefrom |
| CA2808528A1 (en) * | 2010-08-27 | 2012-03-01 | Biomimedica, Inc. | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same |
-
2009
- 2009-03-23 US US12/409,359 patent/US20090240337A1/en not_active Abandoned
- 2009-03-23 WO PCT/US2009/037979 patent/WO2009117737A2/en not_active Ceased
- 2009-03-23 EP EP09722735A patent/EP2268331A2/en not_active Withdrawn
- 2009-03-23 AU AU2009225416A patent/AU2009225416A1/en not_active Abandoned
- 2009-03-23 CA CA2718718A patent/CA2718718A1/en not_active Abandoned
- 2009-03-23 JP JP2011501016A patent/JP2011515162A/ja active Pending
-
2012
- 2012-07-05 US US13/542,464 patent/US20120277807A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009117737A2 (en) | 2009-09-24 |
| US20090240337A1 (en) | 2009-09-24 |
| WO2009117737A3 (en) | 2010-11-04 |
| CA2718718A1 (en) | 2009-09-24 |
| JP2011515162A (ja) | 2011-05-19 |
| US20120277807A1 (en) | 2012-11-01 |
| EP2268331A2 (en) | 2011-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20120277807A1 (en) | Methods, Devices and Compositions for Adhering Hydrated Polymer Implants to Bone | |
| US10752768B2 (en) | Orthopedic implants having gradient polymer alloys | |
| EP3235522A1 (en) | Orthopedic implants having gradient polymer alloys | |
| AU2001285488A1 (en) | Method for mammalian joint resurfacing | |
| AU2020305595B2 (en) | Plug-shaped implant for the replacement and regeneration of biological tissue and method for preparing the implant | |
| JP7584153B2 (ja) | 生体組織の置換および再生のためのプラグ形状インプラント、ならびにインプラントを調製するための方法 | |
| US11426487B2 (en) | Property changing implant | |
| US20070225811A1 (en) | Conformable orthopedic implant | |
| AU2020303837B2 (en) | Plug-shaped implant for the replacement and regeneration of biological tissue and method for preparing the implant | |
| CN115667344B (zh) | 聚合物组合物和制造医用植入物的方法 | |
| US20070173949A1 (en) | Bonding system for orthopedic implants | |
| NL2027199B1 (en) | Method of manufacturing a non-biodegradable plug-shaped implant for the replacement and regeneration of biological tissue | |
| CA2243154A1 (en) | Biomaterial system for in situ tissue repair | |
| MXPA04007061A (en) | Interpositional arthroplasty system and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |